Search
- Presentation
Presentation by Michael Cohen, an analyst in CBO’s Health Analysis Division, and Tamara Hayford, Chief of CBO’s Health Policy Studies Unit, at the Congressional Research Service.
- Report
CBO examines trends in nationwide spending on prescription drugs over the 1980–2018 period. CBO also provides a detailed analysis of trends in spending, use, and prices in the Medicare Part D and Medicaid programs over the 2009–2018 period.
- Cost Estimate
As ordered reported by the Senate Committee on Veterans’ Affairs on December 15, 2021
- Cost Estimate
As ordered reported by the Senate Committee on Veterans’ Affairs on December 15, 2021
- Cost Estimate
As ordered reported by the Senate Committee on Veterans’ Affairs on December 15, 2021
- Report
In a response to Congressman Palmer, CBO summarizes its recent analysis of the costs of making permanent some of the policies in the Build Back Better Act.
- Report
CBO responds to a question from Senator Schumer about its analysis of the costs of making permanent some of the provisions of the Build Back Better Act.
- Report
CBO and the Joint Committee on Taxation project the budgetary effects, including the effects on interest costs, of a modified version of H.R. 5376, the Build Back Better Act, that would make various policies permanent rather than temporary.
- Presentation
The Build Back Better Act includes provisions that would result in new federal spending for home- and community-based services (HCBS) provided by Medicaid. Those provisions would affect states, caregivers, and people who use HCBS.
- Presentation
The Build Back Better Act would establish a program whereby the federal government would provide paid family and medical leave for eligible workers. That program would affect workers, employers, and states.